
Week In Review: Full-Life Acquires Focus-X And Its 8 Radiotherapeutics
MF3d Deals and financings Full-Life Technologies, a year-old Brussels-Shanghai radiotherapeutics company, will acquire New Jersey’s Focus-X Therapeutics for up to $245 million (see story). Using its proprietary peptide engineering technology. Focus-X has built a portfolio […]